Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05012163 · ClinicalTrials.gov registry record · NA

Lottery Incentive Nudges to Increase Influenza Vaccinations

A NA study, sponsored by National Bureau of Economic Research.

Completed
Registry status
NA
Development phase
57,581
Enrollment target

NCT05012163: Completed NA study, sponsored by National Bureau of Economic Research.

NCT05012163 is a NA study that has completed, run by National Bureau of Economic Research. The registered enrollment target is 57,581 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (4004% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05012163, a NA study, has completed, sponsored by National Bureau of Economic Research.

COMPLETED
Registry status
NA
Development phase
57,581 participants
Enrollment target

Study Summary

In the current study, the study team will explore whether small incentives are effective at promoting flu vaccine uptake. The study is designed to compare the relative efficacy of incentives of equal perceived expected value (EV) or equal implementation costs, to assess whether people are more likely to get vaccinated in response to lotteries with very high payoffs than to small certain cash payout or slightly higher-probability, more moderate payoffs. In particular, given the potential appeal of official state lottery tickets, one study arm will receive a Pennsylvania scratch-off lottery ticket for getting a flu vaccine. A primary hypothesis is that lotteries will outperform simple reminders (encouraging respondents to get the flu shot at their upcoming appointment) and the standard of care, representing the ambient healthcare system and public health campaigns to increase vaccination.

Primary Outcome

Received flu vaccination at relevant PCP or specialty appointment.

Interventions

  • BEHAVIORAL Lottery
  • BEHAVIORAL Reminder
  • BEHAVIORAL Financial incentive

Trial Details

FieldValue
Enrollment Target 57,581 participants
Start Date 2021-09-04
Est. Completion 2022-12-31
Phase NA

What the finished NCT05012163 record still lists

NCT05012163 is an interventional study that assigns participants to a tested intervention. Its 57,581 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (4004% higher).

The record links to 0 conditions, and to 3 interventions - of which Lottery is the first listed.

NCT05012163 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05012163 about?

NCT05012163 is a clinical study titled "Lottery Incentive Nudges to Increase Influenza Vaccinations". In the current study, the study team will explore whether small incentives are effective at promoting flu vaccine uptake. The study is designed to compare the relative efficacy of incentives of equal perceived expected value (EV) or equal implementation costs, to assess whether people are more likel...

What is the current status of trial NCT05012163?

This trial is currently completed. It is a NA study. The enrollment target is 57,581 participants. The study started on 2021-09-04. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT05012163?

The interventions under investigation include: Lottery (BEHAVIORAL), Reminder (BEHAVIORAL), Financial incentive (BEHAVIORAL).

Who is sponsoring clinical trial NCT05012163?

This trial is sponsored by National Bureau of Economic Research, which has 14 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05012163's enrollment target sits among peer trials

57,581 7th of 2000 higher than 1,994 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00785525 · 60,000 participants · Phase 3

    Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

  • NCT01825499 · 60,000 participants

    Vermont Oxford Network Very Low Birth Weight Database

  • NCT02850588 · 60,000 participants

    SVS VQI TransCarotid Revascularization Surveillance Project

  • NCT03752840 · 60,200 participants · NA

    Village-Integrated Eye Worker Trial II

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05012163, the US trial registry maintained by the National Library of Medicine. NCT05012163 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.